Cargando…
Preadmission Statin Treatment and Outcome in Patients Hospitalized With COVID-19
Preadmission statin therapy is associated with improved outcome in patients hospitalized with COVID-19. Whether inhibition of inflammation and myocardial injury are in part responsible for this observation has not been studied. The aim of the present study was to relate preadmission statin usage to...
Autores principales: | Saad, Marwan, Kennedy, Kevin F., Louis, David W., Imran, Hafiz, Sherrod, Charles F., Aspry, Karen, Mentias, Amgad, Poppas, Athena, Abbott, J. Dawn, Aronow, Herbert D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194874/ https://www.ncbi.nlm.nih.gov/pubmed/35715239 http://dx.doi.org/10.1016/j.amjcard.2022.04.045 |
Ejemplares similares
-
Preadmission Oral Anticoagulation for Atrial Fibrillation/Flutter and Death or Thrombotic Events During COVID-19 Admission
por: Louis, David W., et al.
Publicado: (2022) -
PRE-ADMISSION ORAL ANTICOAGULATION IS ASSOCIATED WITH FEWER THROMBOTIC COMPLICATIONS IN PATIENTS ADMITTED WITH COVID-19
por: Louis, David, et al.
Publicado: (2022) -
Preadmission Statin Prescription and Inpatient Myocardial Infarction in Geriatric Hip Fracture
por: Tarrant, Seth M., et al.
Publicado: (2021) -
Preadmission statin use and one-year mortality among patients in intensive care - A cohort study
por: Christensen, Steffen, et al.
Publicado: (2010) -
Association of Preadmission Statin Use and Mortality in Critically Ill Patients: A Meta-Analysis of Cohort Studies
por: Yu, Shao-shuo, et al.
Publicado: (2021)